ArticleBMC surgery2025
Is biological mesh a suitable option for laparoscopic intraperitoneal onlay mesh plus (IPOM plus) repair in the treatment of abdominal wall hernias?
Article in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe aim of this study was to evaluate the safety and efficacy of biological mesh in laparoscopic intraperitoneal onlay mesh plus (IPOM plus) repair of abdominal wall hernias.
methodsFrom January 2021 to January 2022, the clinical data of 30 patients with various types of abdominal wall hernias were analyzed. All patients underwent laparoscopic IPOM plus repair, during which the hernia defect was closed with non-absorbable sutures prior to placement of the biological mesh. Preoperative general information, as well as complications, adverse events, and hospitalization costs, were monitored and analyzed.
resultsIn this study, the patients' ages ranged from 28 to 65 years, and the length of their hospital stays ranged from 4 to 10 days. The surgical method employed was laparoscopic IPOM plus repair, with operation times ranging from 50 to 80 min. Follow-up evaluations were conducted at 7 days, 1 month, 3 months, 6 months, 1 year, and 2 years post-operation. No patients were lost to follow-up during this period. Additionally, there were no cases of abdominal hernia recurrence, intestinal fistula, intestinal obstruction, wound infection, mesh infection, chronic pain, or foreign body sensation. One patient developed seroma, which was cured via drainage. The patients' hospitalization costs ranged from $4,211 to $8,307 USD.
conclusionThe use of biological mesh for laparoscopic IPOM plus repair with non-absorbable suture closure of the hernia defect is both effective and safe, making it a valuable option for clinical application, especially for young patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.